Y Intercept (Hong Kong) LTD Immunocore Holdings PLC Transaction History
Y Intercept (Hong Kong) LTD
- $3.83 Billion
- Q3 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 45,331 shares of IMCR stock, worth $1.46 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
45,331
Previous 51,663
12.26%
Holding current value
$1.46 Million
Previous $1.62 Million
1.54%
% of portfolio
0.04%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding IMCR
# of Institutions
148Shares Held
45.1MCall Options Held
297KPut Options Held
1.19M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.07MShares$228 Million0.14% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$157 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$136 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$121 Million0.1% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$78.6 Million1.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.41B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...